London & Capital Asset Management’s Pfizer PFE Stock Holding History

London & Capital Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Sell	9,685 -310	-3%	-$8.25K	﹤0.01%	204
2025 Q4	$249K	Buy	+9,995	New	+$252K	﹤0.01%	219
2020 Q3	–	Sell	-9,367	Closed	-$291K	–	95
2020 Q2	$291K	Sell	9,367 -1,367	-13%	-$46.4K	0.05%	89
2020 Q1	$332K	Sell	10,734 -205	-2%	-$6.99K	0.08%	61
2019 Q4	$407K	Sell	10,939 -1,603	-13%	-$57.1K	0.07%	71
2019 Q3	$428K	Buy	12,542 +935	+8%	+$34K	0.07%	66
2019 Q2	$477K	Sell	11,607 -447	-4%	-$17.8K	0.1%	66
2019 Q1	$486K	Hold	12,054	–	–	0.07%	59
2018 Q4	$499K	Buy	+12,054	New	+$500K	0.08%	65

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

London & Capital Asset Management's PFE Position: Q1 2026 in Review

London & Capital Asset Management reduced its Pfizer (PFE) stake by 3.1% in Q1 2026, selling an estimated $8.25K and leaving 9,685 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

London & Capital Asset Management first reported a position in PFE in Q4 2018 and has held it in 9 quarters since. The position peaked at $499K in Q4 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

London & Capital Asset Management held 9,685 shares of Pfizer worth $272K as of Q1 2026.
London & Capital Asset Management sold 310 Pfizer shares in Q1 2026, an estimated $8.25K.
Pfizer made up ﹤0.01% of London & Capital Asset Management's portfolio in Q1 2026, its #204 holding.
London & Capital Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 9 quarters since.
London & Capital Asset Management's Pfizer position peaked at $499K in Q4 2018.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on London & Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.